389 related articles for article (PubMed ID: 22405502)
1. Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model.
Goebel-Goody SM; Wilson-Wallis ED; Royston S; Tagliatela SM; Naegele JR; Lombroso PJ
Genes Brain Behav; 2012 Jul; 11(5):586-600. PubMed ID: 22405502
[TBL] [Abstract][Full Text] [Related]
2. STEP inhibition reverses behavioral, electrophysiologic, and synaptic abnormalities in Fmr1 KO mice.
Chatterjee M; Kurup PK; Lundbye CJ; Hugger Toft AK; Kwon J; Benedict J; Kamceva M; Banke TG; Lombroso PJ
Neuropharmacology; 2018 Jan; 128():43-53. PubMed ID: 28943283
[TBL] [Abstract][Full Text] [Related]
3. Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome.
Thomas AM; Bui N; Graham D; Perkins JR; Yuva-Paylor LA; Paylor R
Behav Brain Res; 2011 Oct; 223(2):310-21. PubMed ID: 21571007
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered Arc translation and long-term depression.
Niere F; Wilkerson JR; Huber KM
J Neurosci; 2012 Apr; 32(17):5924-36. PubMed ID: 22539853
[TBL] [Abstract][Full Text] [Related]
5. Impaired activity-dependent FMRP translation and enhanced mGluR-dependent LTD in Fragile X premutation mice.
Iliff AJ; Renoux AJ; Krans A; Usdin K; Sutton MA; Todd PK
Hum Mol Genet; 2013 Mar; 22(6):1180-92. PubMed ID: 23250915
[TBL] [Abstract][Full Text] [Related]
6. Deletion of Fmr1 in parvalbumin-expressing neurons results in dysregulated translation and selective behavioral deficits associated with fragile X syndrome.
Kalinowska M; van der Lei MB; Kitiashvili M; Mamcarz M; Oliveira MM; Longo F; Klann E
Mol Autism; 2022 Jun; 13(1):29. PubMed ID: 35768828
[TBL] [Abstract][Full Text] [Related]
7. Activation of 5-HT7 serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and Fmr1 knockout mice, a model of Fragile X syndrome.
Costa L; Spatuzza M; D'Antoni S; Bonaccorso CM; Trovato C; Musumeci SA; Leopoldo M; Lacivita E; Catania MV; Ciranna L
Biol Psychiatry; 2012 Dec; 72(11):924-33. PubMed ID: 22817866
[TBL] [Abstract][Full Text] [Related]
8. Loss of the fragile X mental retardation protein decouples metabotropic glutamate receptor dependent priming of long-term potentiation from protein synthesis.
Auerbach BD; Bear MF
J Neurophysiol; 2010 Aug; 104(2):1047-51. PubMed ID: 20554840
[TBL] [Abstract][Full Text] [Related]
9. Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome.
Osterweil EK; Krueger DD; Reinhold K; Bear MF
J Neurosci; 2010 Nov; 30(46):15616-27. PubMed ID: 21084617
[TBL] [Abstract][Full Text] [Related]
10. Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.
Nosyreva ED; Huber KM
J Neurophysiol; 2006 May; 95(5):3291-5. PubMed ID: 16452252
[TBL] [Abstract][Full Text] [Related]
11. Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome.
Maurin T; Melancia F; Jarjat M; Castro L; Costa L; Delhaye S; Khayachi A; Castagnola S; Mota E; Di Giorgio A; Servadio M; Drozd M; Poupon G; Schiavi S; Sardone L; Azoulay S; Ciranna L; Martin S; Vincent P; Trezza V; Bardoni B
Cereb Cortex; 2019 Jul; 29(8):3241-3252. PubMed ID: 30137253
[TBL] [Abstract][Full Text] [Related]
12. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY
Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536
[TBL] [Abstract][Full Text] [Related]
13. Disruption of GpI mGluR-Dependent Cav2.3 Translation in a Mouse Model of Fragile X Syndrome.
Gray EE; Murphy JG; Liu Y; Trang I; Tabor GT; Lin L; Hoffman DA
J Neurosci; 2019 Sep; 39(38):7453-7464. PubMed ID: 31350260
[TBL] [Abstract][Full Text] [Related]
14. Taking STEPs forward to understand fragile X syndrome.
Goebel-Goody SM; Lombroso PJ
Results Probl Cell Differ; 2012; 54():223-41. PubMed ID: 22009355
[TBL] [Abstract][Full Text] [Related]
15. Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome.
Gross C; Nakamoto M; Yao X; Chan CB; Yim SY; Ye K; Warren ST; Bassell GJ
J Neurosci; 2010 Aug; 30(32):10624-38. PubMed ID: 20702695
[TBL] [Abstract][Full Text] [Related]
16. c-Jun N-terminal kinase regulates mGluR-dependent expression of post-synaptic FMRP target proteins.
Schmit TL; Dowell JA; Maes ME; Wilhelm M
J Neurochem; 2013 Dec; 127(6):772-81. PubMed ID: 24047560
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1-Mediated Cholesterol Accumulation Contributes to Exaggerated mGluR-Dependent Long-Term Depression and Impaired Cognition in Fmr1 Knockout Mice.
Luo L; Yang L; Zhang K; Zhou SM; Wang Y; Yang LK; Feng B; Liu SB; Wu YM; Zhao MG; Yang Q
Mol Neurobiol; 2023 Jun; 60(6):3379-3395. PubMed ID: 36854997
[TBL] [Abstract][Full Text] [Related]
18. Effects of the presence and absence of amino acids on translation, signaling, and long-term depression in hippocampal slices from Fmr1 knockout mice.
Cooke SK; Russin J; Moulton K; Nadel J; Loutaev I; Gu Q; Li Z; Smith CB
J Neurochem; 2019 Dec; 151(6):764-776. PubMed ID: 31539452
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome.
Muddashetty RS; Kelić S; Gross C; Xu M; Bassell GJ
J Neurosci; 2007 May; 27(20):5338-48. PubMed ID: 17507556
[TBL] [Abstract][Full Text] [Related]
20. Reversal of fragile X phenotypes by manipulation of AβPP/Aβ levels in Fmr1KO mice.
Westmark CJ; Westmark PR; O'Riordan KJ; Ray BC; Hervey CM; Salamat MS; Abozeid SH; Stein KM; Stodola LA; Tranfaglia M; Burger C; Berry-Kravis EM; Malter JS
PLoS One; 2011; 6(10):e26549. PubMed ID: 22046307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
